The abstract is read at the publisher; the summary is JClub's.
A 14-protein plasma signature predicts lung cancer more than 5 years before diagnosis, validated across eight cohorts and linked to smoking and particulate matter exposure.
- Why it matters: Lung cancer prevention trials need better risk stratification because IL-1β inhibition reduces incidence but has a high NNT in unselected populations.
- What they did: Using machine learning on plasma, the study built and validated a 14-protein signature across eight cohorts, then connected it to lung myeloid and alveolar cells and to an EGFR-driven KAC state.
- The result: In EGFR-driven lung adenocarcinoma models, PM, oncogenic EGFR, or IL-1β induced the signature and KAC programs, while IL-1β inhibition restrained PM-driven KAC expansion and early tumorigenesis; in CANTOS, the signature identified individuals with greater benefit, lowering the NNT threshold.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.